Topic
allergy
1 stories related to this topic, newest first.
politics1 day ago
Drug Barzolvolimab Shows Sustained Angioedema Relief in CSU Patients Seven Months After Dosing
Phase 2 data presented at a medical meeting found that barzolvolimab produced rapid and lasting reductions in angioedema for patients with antihistamine-refractory chronic spontaneous urticaria. Improvements began within one week and continued through 52 weeks of treatment, remai…